Shareholders Equity: The sum of preferred and common equity items.
Athira Pharma, Inc. (ATHA) had Shareholders Equity of $44.84M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-96.94M |
|
-- |
|
-- |
|
$100.90M |
|
$-100.90M |
|
$3.96M |
|
$-96.94M |
|
$-96.94M |
|
$-96.94M |
|
$-96.94M |
|
$-96.94M |
|
$-96.94M |
|
$-100.90M |
|
$-100.45M |
|
38.48M |
|
38.48M |
|
$-2.52 |
|
$-2.52 |
|
| Balance Sheet Financials | |
$54.84M |
|
$2.44M |
|
$3.94M |
|
$58.78M |
|
$13.13M |
|
-- |
|
$0.80M |
|
$13.94M |
|
$44.84M |
|
$44.84M |
|
|
Shareholders Equity |
$44.84M |
39.04M |
|
| Cash Flow Statement Financials | |
$-97.17M |
|
$54.83M |
|
$0.19M |
|
$91.22M |
|
$49.07M |
|
$-42.15M |
|
$11.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-97.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-216.19% |
|
-216.19% |
|
-164.92% |
|
-216.19% |
|
$1.15 |
|
$-2.53 |
|
$-2.53 |
|